Yang Na | Chemistry | Best Researcher Award

Posted on by ScienceFather

Dr. Yang Na | Chemistry | Best Researcher Award

Associate professor at University of Electronic Science and Technology of China, China

Dr. Na Yang (b. Jan 1992) is an Associate Professor at the School of Materials and Energy, University of Electronic Science and Technology of China, Chengdu 🇨🇳. She earned her Ph.D. in Chemical Engineering and Technology from Chongqing University and completed postdoctoral research under Prof. Zhongwei Chen at South China Normal University and the University of Waterloo 🇨🇦. Her research focuses on density functional theory (DFT)🧠, ab initio molecular dynamics (AIMD)🧪, catalyst design🧲, and electrochemical mechanisms⚡. With an H-index of 15, Dr. Yang has published in high-impact journals like Angewandte Chemie, Advanced Materials, and ACS Energy Letters 📚. She has contributed significantly to the fields of CO₂ reduction, oxygen reduction reactions, and nitrogen fixation catalysis 🌱.

Publication Profile

Scopus Profile

Research Fields

Dr. Yang Na’s research spans several cutting-edge areas in materials science and energy technology ⚙️⚡. Her primary expertise lies in density functional theory (DFT) and ab initio molecular dynamics (AIMD), which she uses to model and simulate material behavior at the atomic level 🧬💻. She is deeply involved in the design and screening of catalysts for various energy applications, focusing on improving efficiency and stability 🔍🔋. Dr. Yang also works on the preparation of new highly active catalysts, utilizing advanced synthesis techniques to enhance catalytic performance 🧪⚗️. Another key area of her research is the exploration of electrochemical catalytic mechanisms, where she investigates fundamental reaction pathways to optimize energy conversion processes such as hydrogen evolution and oxygen reduction 🌱⚡. Through these interdisciplinary approaches, Dr. Yang contributes significantly to the development of sustainable and high-performance energy materials for a greener future 🌍🔧

🎓 Educational Background

Dr. Yang Na earned her Ph.D. in Chemical Engineering and Technology from Chongqing University, Chongqing, China, where she studied from September 2014 to June 2020 🧪🎓. Under the expert mentorship of Professor Li Li, she developed a strong foundation in advanced chemical engineering principles and materials research 🔬📘. Her doctoral studies involved in-depth exploration of catalyst design, electrochemical energy conversion, and computational modeling, laying the groundwork for her current contributions to energy materials and catalysis research 💡⚙️. The rigorous academic environment at Chongqing University provided her with both theoretical knowledge and hands-on research experience, enabling her to tackle real-world energy challenges with innovative scientific approaches 🌍💻. Dr. Yang’s time at Chongqing University was instrumental in shaping her expertise in computational chemistry, materials synthesis, and electrochemical systems, which continue to define her career as a forward-thinking and impactful researcher in the field of materials science and energy technology ⚛️🔋.

💼 Professional Experience

From September 2020 to September 2022, Dr. Yang Na undertook postdoctoral research that significantly advanced her expertise in materials and energy science 🌱🔬. She began her postdoctoral journey at the School of Information and Optoelectronic Science and Engineering, South China Normal University, Guangdong, China, where she worked under the mentorship of Prof. Zhongwei Chen 📡🧠. During this period, she focused on optoelectronic materials and their applications in energy systems.

Simultaneously, Dr. Yang continued her postdoctoral research at the School of Chemistry and Chemical Engineering, University of Waterloo, Ontario, Canada 🍁⚗️. Under the same mentorship of Prof. Chen, she deepened her research into electrocatalysis and advanced energy storage materials, contributing to cutting-edge developments in sustainable energy technologies 🔋🌍. These international and interdisciplinary experiences enriched her research perspective and equipped her with global insights into innovation and collaboration in the materials science domain 🌐🧪.

Research Focus

Dr. Yang Na specializes in cutting-edge research within the fields of catalysis, energy materials, and sustainable chemistry ⚗️🔋. Her work spans a diverse range of topics including electrocatalysis, chemical looping reforming, CO₂ photoreduction, and ammonia synthesis. Using advanced techniques like density functional theory (DFT) and ab initio molecular dynamics (AIMD), she designs and screens highly active catalysts for clean energy conversion 🌱🌍. Her contributions to perovskite-based and polymer dielectric materials show a strong interdisciplinary approach, connecting materials science, environmental engineering, and green chemistry ♻️🧪. Dr. Yang’s research plays a vital role in promoting efficient energy solutions.

Conclusion

Dr. Yang Na’s exceptional research in renewable energy, particularly her work on catalytic mechanisms and material design for electrochemical reactions, positions her as an outstanding candidate for the “Best Researcher Award.” Her contributions to both theoretical and practical aspects of energy research make her a leader in the field, and her continued work promises to bring lasting impacts to sustainable energy solutions.

Publication Top Notes

  • 🔬 Tailoring active lattice oxygen in CeO₂-Based oxygen carriers for enhanced chemical looping dry reforming of methane – Journal of the Energy Institute, 2025  📄

  • ⚡ NiFe-based arrays with MnO₂ enhance chloride blocking for durable alkaline seawater oxidation – Journal of Colloid and Interface Science, 2025 | 1 citation 💧

  • 🌞 Rational Design of Methylated Triazine-Based Polymers for CO₂ Photoreduction with Water – Advanced Materials, 2025  📘

  • 🧪 Durable, Super-Resilient Polyurethane Elastomers via Hydrogen Bond Cross-Linking – Macromolecules, 2025 🧵

  • 🧫 Axial Cl-Induced Symmetry-Breaking Iron SAC for Electrochemical Ammonia Synthesis – ACS Catalysis, 2025 ⚗️

  • 🔌 All-organic dielectric PP-based polymer with high breakdown strength – Polymer, 2025  ⚡

  • 🧴 Mini-review: Indium-oxide based catalysts for CO₂ to methanol – 2025  📚

  • 💡 Lattice Oxygen Redox in Zeolite-Encapsulated CsPbBr₃ Perovskites for OER – Advanced Science, 2025 🌐

  • 🔄 Real-Time Detection in KNixFe₁₋ₓF₃ Perovskites for Water Oxidation – Small, 2025 | 1 citation 🔍

  • 💧 Water dissociation via bimetallic phosphide & Mn oxide for alkaline HER – Nano Research, 2025  🌊

Yaojia Jiang | Organic Chemistry | Best Researcher Award

Posted on by ScienceFather

Mr. Yaojia Jiang | Organic Chemistry | Best Researcher Award

Professor from Guizhou University, China

Yaojia Jiang is an accomplished chemist with a strong academic and research background in radical chemistry, carbene and nitrene chemistry, and biological sciences. His academic journey showcases steady growth under the mentorship of highly respected scholars and at leading institutions. After earning his Master’s degree at Soochow University in 2010, he pursued a Ph.D. at Nanyang Technological University, completing it in 2014. During his doctoral studies, he specialized in carbene and nitrene transformations, a highly significant area of research with broad applications in organic synthesis. Jiang then expanded his expertise through postdoctoral work in biological sciences, which added a multidisciplinary dimension to his research profile. His independent career began in 2015 at Nanjing Tech University, focusing on carbene transformations, and later advanced at Guizhou University, where his work centers on modular single-carbon insertion reactions and sustainable pesticide development. His research combines fundamental chemistry with applications that address real-world problems, particularly in agriculture and green chemistry. Yaojia Jiang’s career path highlights not only technical expertise but also innovation, adaptability, and an ongoing commitment to sustainability and atom-economical processes. His diverse experiences position him as a leading figure in advancing chemical sciences in environmentally conscious ways.

Professional Profile

Education

Yaojia Jiang’s educational journey reflects strong academic foundations and strategic specialization in areas of growing scientific importance. He earned his Master’s degree in 2010 from Soochow University under the supervision of Professor Jian-Ping Zou, specializing in radical chemistry. This early focus provided him with a rigorous understanding of reactive intermediates and set the stage for his future contributions to the field. In 2014, he completed his Ph.D. at Nanyang Technological University (NTU) in Singapore, one of Asia’s leading research institutions. His doctoral research, supervised by Professors Cheol-Min Park and Teck-Peng Loh, delved into the chemistry of carbenes and nitrenes, reactive species crucial in modern organic synthesis. His Ph.D. work significantly enhanced his expertise in reaction mechanisms and synthetic methods, skills essential for high-level chemical innovation. Jiang’s educational experiences at two prominent institutions, combined with mentorship from globally respected scientists, provided him with both theoretical depth and practical skills. His academic background was further diversified through postdoctoral research in biological sciences, broadening his interdisciplinary knowledge and positioning him well for independent research that bridges chemistry and applied life sciences.

Professional Experience

Yaojia Jiang began his independent academic career shortly after completing his postdoctoral studies. In 2015, he joined Nanjing Tech University, where he focused on carbene transformations, contributing important research on highly reactive intermediates and their controlled manipulation for synthetic applications. His early years as an independent researcher showcased a rapid transition from trainee to research leader, reflecting his ability to design, lead, and execute complex chemical research projects. Subsequently, Jiang moved to Guizhou University, a rising hub for scientific research in China. At Guizhou University, he expanded his research portfolio by focusing on modular single-carbon insertion reactions and their applications in pesticide design. His work at Guizhou emphasizes green chemistry principles and atom-economical strategies, aligning his research with global calls for sustainable innovation. Over the course of his professional career, Jiang has demonstrated a unique combination of deep technical expertise and practical application, consistently pushing the boundaries of synthetic chemistry. His progression from graduate student to a respected academic researcher in a relatively short span reflects both his scientific excellence and leadership capabilities.

Research Interest

Yaojia Jiang’s research interests center around reactive intermediates, especially carbenes and nitrenes, and their controlled transformations for synthetic applications. His early work in radical chemistry laid the foundation for a deep understanding of highly reactive species, leading to advanced exploration of carbene and nitrene chemistries during his Ph.D. training. Jiang is particularly fascinated by modular single-carbon insertion reactions, which offer precise control over molecular architecture and have significant implications in developing functional molecules. His current research aims to apply these reactions toward the design of new, environmentally friendly pesticides using green and atom-economical processes. This focus bridges fundamental organic chemistry with real-world applications in agriculture and environmental protection. His interdisciplinary approach, integrating organic synthesis with biological insights from his postdoctoral experience, allows him to pursue research topics that are both intellectually challenging and socially impactful. In an era where sustainable chemical processes are increasingly vital, Jiang’s research direction positions him at the forefront of green innovation in synthetic chemistry. His ongoing projects reflect a balance of fundamental scientific curiosity and a commitment to contributing solutions to pressing global challenges.

Research Skills

Yaojia Jiang possesses an extensive range of research skills that make him highly effective as a synthetic chemist and innovator. His expertise in radical, carbene, and nitrene chemistry provides him with a strong foundation in handling reactive intermediates and understanding complex reaction mechanisms. He is skilled in the design and execution of multi-step organic synthesis, employing both classical methods and cutting-edge techniques. His experience with biological sciences during his postdoctoral training broadened his technical capabilities to include interdisciplinary methods, blending chemistry with biological systems analysis. Jiang’s research emphasizes green chemistry and atom-economical strategies, requiring a keen understanding of reaction efficiency, catalyst design, and sustainable process development. His work also demonstrates strong skills in experimental planning, data analysis, and scientific writing, evidenced by his successful transition into independent research leadership. Jiang has shown proficiency in mentoring younger researchers and managing laboratory activities, essential skills for building and maintaining a productive research team. His methodological rigor, creativity in problem-solving, and adaptability to new research challenges underscore his profile as a highly skilled and versatile researcher ready for larger international scientific collaborations and leadership roles.

Award and Honors

Although specific awards and honors for Yaojia Jiang were not listed in the provided information, his career progression itself is a testament to his excellence. Successfully obtaining a Ph.D. from a prestigious institution such as Nanyang Technological University under the mentorship of world-renowned scientists is a strong indicator of his academic and research capabilities. Securing independent research positions at respected universities like Nanjing Tech University and Guizhou University reflects institutional recognition of his potential and contributions. His rapid transition to an independent career and his ability to sustain and develop research programs in competitive environments suggest that he has earned professional respect in the field of synthetic and green chemistry. In future stages of his career, additional formal recognitions such as international awards, research grants, or leadership appointments in scientific societies could further highlight his achievements. Overall, Yaojia Jiang’s track record positions him well for future honors as he continues to contribute significantly to the advancement of chemical sciences and sustainable technologies.

Conclusion

Yaojia Jiang exemplifies the qualities of a forward-thinking and highly capable researcher in the field of synthetic and green chemistry. His strong academic background, diverse research experiences, and focus on addressing real-world challenges through innovative chemical processes make him a standout figure in modern scientific research. His work on carbene transformations and modular single-carbon insertion reactions, with applications in sustainable pesticide development, reflects a rare combination of deep scientific understanding and social responsibility. While his profile would be further strengthened by greater international recognition and large-scale collaborations, his current achievements already demonstrate significant excellence and impact. Yaojia Jiang is on a clear path toward becoming a global leader in green chemistry and synthetic innovation. His ongoing dedication to sustainable chemical solutions and his ability to adapt and expand his research interests mark him as an ideal candidate for future prestigious awards and broader academic leadership roles.

Publications Top Notes

  1. Title: Discovery of Novel Antibacterial Agents against Plant Pathogens: Design, Synthesis, Antibacterial Activity, and Mechanism of Action of 1,2,4-Thiadiazole Derivatives Containing a Sulfone Moiety

    • Authors: Zou Yue, Zhu Mei, Zhu Zongnan, Jiang Yaojia, Chen Jixiang

    • Year: 2025

  2. Title: Synthesis of Functionalized Cycloheptadienones Starting from Phenols and Using a Rhodium/Boron Asymmetric Catalytic System

    • Authors: Han Jiabin, Fan Yaxin, Yang Xiaoyan, Hao Gefei, Jiang Yaojia

    • Year: 2025

    • Citations: 1

  3. Title: Pd(II) Auxiliary Assembling and Diverse Transformations via Inert C(sp³)-H Bond Activation

    • Authors: Luo Jiangbin, Chen Jie, Yang Xiaoyan, Hao Gefei, Jiang Yaojia

    • Year: 2025

  4. Title: Nickel-Catalyzed Multicomponent Assembly of Alkynes Toward α‑CF₃‑Alkenes

    • Authors: Li Ling, Li Yingmei, Yan Chongchong, Zhang Jian, Jiang Yaojia

    • Year: 2024

Sutha Devaraj | Pharmaceutical Science | Best Academic Researcher Award

Posted on by ScienceFather

Dr. Sutha Devaraj | Pharmaceutical Science | Best Academic Researcher Award

Deputy Dean from Perdana University, Malaysia 

Sutha Devaraj is a dedicated researcher and academician with expertise in pharmaceutical sciences, specializing in drug discovery and pharmacology. She earned her Ph.D. in Pharmaceutical Sciences from Universiti Sains Malaysia (USM) in 2018, where her research focused on the development of optimized methods for preparing bioactive fractions of Strobilanthes crispus (L.) Bremek. Her work involved the quantification of the plant’s marker compound, contributing to advancements in natural product-based drug discovery. Before completing her Ph.D., Sutha obtained a Master’s in Pharmacology from USM in 2012. Her master’s thesis focused on the hepatoprotective properties of Curcuma xanthorrhiza Rox, exploring its potential for liver protection through its bioactive compounds. She also holds a B.Sc. (Hons) in Biotechnology from AIMST University, Malaysia, where she graduated with a CGPA of 3.41. This academic foundation in biotechnology provided her with a strong understanding of molecular biology and biochemistry, essential for her later research in pharmacology and drug development. Throughout her career, Sutha has contributed significantly to the study of plant-based compounds with medicinal properties, and her work has enhanced the understanding of their therapeutic potential. Her academic journey has been marked by a consistent focus on integrating practical research with innovative approaches in pharmaceutical sciences.

Professional Profile

Education

Sutha Devaraj’s educational background is distinguished by her specialized studies in pharmaceutical sciences and pharmacology. She earned her Ph.D. in Pharmaceutical Sciences with a focus on Drug Discovery from Universiti Sains Malaysia (USM) in 2018. Her doctoral thesis, titled Development of an Optimized Method for the Preparation of Bioactive Fraction of Strobilanthes crispus (L.) Bremek and the Quantification of its Marker Compound, was instrumental in advancing research on bioactive compounds derived from natural sources. This work enhanced the understanding of the therapeutic potentials of Strobilanthes crispus, contributing to both pharmaceutical science and ethnomedicine. Before completing her Ph.D., Sutha obtained her Master of Science (M.Sc.) in Pharmacology from USM in 2012. Her research focused on the hepatoprotective and pharmacological properties of Curcuma xanthorrhiza Rox, and she published findings related to the effectiveness of its standardized ethanolic extract in protecting the liver, demonstrating her expertise in pharmacological testing and drug development. Sutha’s academic journey began with a Bachelor of Science (B.Sc.) in Biotechnology (Hons) from AIMST University in 2008, where she graduated with a CGPA of 3.41. This early foundation in biotechnology paved the way for her subsequent advanced studies in pharmacology and pharmaceutical sciences.

Professional Experience

Sutha Devaraj has accumulated significant experience in the field of pharmaceutical sciences and pharmacology. Throughout her career, she has worked with various academic and research institutions, where she has contributed to advancing the understanding of pharmacological mechanisms and drug discovery. As a researcher at Universiti Sains Malaysia (USM), Sutha has actively participated in projects focusing on the isolation and quantification of bioactive compounds from plants, which has led to important findings on their therapeutic potentials. She has collaborated with both local and international researchers to examine the pharmacological properties of natural products, a focus that has shaped her work in drug discovery. In addition to her research roles, Sutha has also contributed to teaching and mentoring undergraduate and postgraduate students. She has shared her expertise in pharmacology and biotechnology, helping shape the next generation of scientists. Through her work, Sutha has built a strong professional reputation, earning recognition for her in-depth understanding of drug development processes and her ability to implement novel methodologies in her research.

Research Skills

Sutha Devaraj possesses a wide array of research skills essential to her work in pharmaceutical sciences and pharmacology. Her proficiency in bioactive compound isolation and quantification has been demonstrated through her research on Strobilanthes crispus and Curcuma xanthorrhiza, both of which are significant to natural drug discovery. She is highly skilled in pharmacological testing, utilizing a range of in-vitro and in-vivo models to assess the therapeutic efficacy of plant-based extracts. In addition to her experimental capabilities, Sutha has expertise in analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry, which she has used to identify and quantify bioactive compounds in complex matrices. Her background in biotechnology provides her with a solid understanding of biochemical assays, including enzyme inhibition and receptor binding assays. Furthermore, Sutha has honed her skills in data analysis and interpretation, often using sophisticated statistical tools to evaluate research results. Her ability to combine these skills allows her to contribute to cutting-edge research in drug discovery, particularly in exploring new therapeutic agents derived from natural sources.

Research Interests

Sutha Devaraj’s research interests lie at the intersection of pharmacology, drug discovery, and natural products. She is particularly focused on the exploration of plant-based bioactive compounds and their potential applications in pharmaceutical development. Her Ph.D. research on Strobilanthes crispus exemplifies her dedication to the discovery of new therapeutic agents from natural resources. Sutha is passionate about investigating the hepatoprotective and anticancer properties of various plant species, particularly those indigenous to Southeast Asia. She is also interested in the mechanisms of action of these compounds, aiming to elucidate how they interact with biological systems to exert therapeutic effects. In addition to pharmacological studies, Sutha is keen on formulation development, specifically in optimizing methods for the preparation and stabilization of bioactive extracts. Her future research endeavors include furthering the development of natural-based drugs with fewer side effects compared to conventional synthetic drugs, contributing to a more sustainable and effective approach in pharmaceutical therapy.

Awards and Honors

Sutha Devaraj’s career has been marked by notable recognition for her academic and research contributions. She was awarded a PhD Fellowship by Universiti Sains Malaysia (USM), providing her with the opportunity to carry out high-impact research in the field of pharmaceutical sciences. Additionally, her M.Sc. research on Curcuma xanthorrhiza earned her accolades for its significance in hepatoprotective studies. Sutha’s ability to combine scientific rigor with practical applications has led to her work being published in well-respected, peer-reviewed journals. Her academic excellence and contributions to the field have earned her membership in several prestigious academic organizations and editorial positions in prominent journals related to pharmacology and drug development. Her work continues to be recognized by the academic community, highlighting her as an emerging leader in her field of expertise.

Conclusion

In conclusion, Sutha Devaraj is an accomplished researcher with a strong academic background and expertise in pharmacology and drug discovery. Her dedication to advancing natural product research has led to valuable contributions in the areas of bioactive compound isolation and pharmacological evaluation. Sutha’s research skills, which include advanced analytical techniques and experimental methodologies, equip her to make meaningful advances in the development of therapeutic agents. Her research interests reflect a deep commitment to exploring sustainable and effective natural-based drugs, particularly those with hepatoprotective and anticancer properties. With a growing reputation in the field, Sutha’s work continues to inspire innovation in the pharmaceutical sciences, and her achievements and contributions make her a prominent figure in the ongoing search for new, safer therapeutic options.

Publications Top Notes

1. Evaluation of the Antinociceptive Activity and Acute Oral Toxicity of Standardized Ethanolic Extract of the Rhizome of Curcuma xanthorrhiza Roxb

  • Authors: S. Devaraj, A.S. Esfahani, S. Ismail, S. Ramanathan, M.F. Yam

  • Journal: Molecules, 15(4), 2925–2934

  • Year: 2010

  • Citations: 97

2. Investigation of Antioxidant and Hepatoprotective Activity of Standardized Curcuma xanthorrhiza Rhizome in Carbon Tetrachloride‐Induced Hepatic Damaged Rats

  • Authors: S. Devaraj, S. Ismail, S. Ramanathan, M.F. Yam

  • Journal: The Scientific World Journal, 2014(1), 353128

  • Year: 2014

  • Citations: 75

3. Evaluation of the Hepatoprotective Activity of Standardized Ethanolic Extract of Curcuma xanthorrhiza Roxb

  • Authors: S. Devaraj, S. Ismail, S. Ramanathan, S. Marimuthu, Y.M. Fei

  • Journal: Journal of Medicinal Plants Research, 4(23), 2512–2517

  • Year: 2010

  • Citations: 53

4. Anti-Tumor Action, Clinical Biochemistry Profile and Phytochemical Constituents of a Pharmacologically Active Fraction of S. crispus in NMU-Induced Rat Model

  • Authors: N.S. Yaacob, H.M. Yankuzo, S. Devaraj, J.K.M. Wong, C.S. Lai

  • Journal: PLoS One, 10(5), e0126426

  • Year: 2015

  • Citations: 41

5. A Study on the Hepatoprotective Effect of Andrographis paniculata (Burm. F) Nees on Mice

  • Author: D. Sutha

  • Journal: Journal of Phytology, 2(11)

  • Year: 2010

  • Citations: 35

6. In Vivo Toxicological Investigations of Standardized Ethanolic Extract of Curcuma xanthorrhiza Roxb. Rhizome

  • Authors: S. Devaraj, S. Ismail, S. Ramanathan, M. FeiYam

  • Journal: Journal of Natural Products and Plant Resources, 3(1), 67–73

  • Year: 2013

  • Citations: 28

7. Explorations of CRISPR/Cas9 for Improving the Long-Term Efficacy of Universal CAR-T Cells in Tumor Immunotherapy

  • Authors: M. Naeem, A. Hazafa, N. Bano, R. Ali, M. Farooq, S.I. Abd Razak, T.Y. Lee, et al.

  • Journal: Life Sciences, 316, 121409

  • Year: 2023

  • Citations: 23

8. Phytochemical, Antioxidant, Antipyretic and Anti-inflammatory Activities of Aqueous-Methanolic Leaf Extract of Mangifera indica

  • Authors: Q.U. Ain, M.O. Iqbal, I.A. Khan, N. Bano, M. Naeem, M.I. Jamaludin, S. Devaraj

  • Journal: American Journal of Translational Research, 15(7), 4533

  • Year: 2023

  • Citations: 15

9. Pathogenetic Mechanisms of Liver-Associated Injuries, Management, and Current Challenges in COVID-19 Patients

  • Authors: M. Naeem, N. Bano, S. Manzoor, A. Ahmad, N. Munawar, S.I.A. Razak, T.Y. Lee, et al.

  • Journal: Biomolecules, 13(1), 99

  • Year: 2023

  • Citations: 10

10. Innovative Aspects and Applications of Single Cell Technology for Different Diseases

  • Authors: A. Ali, S. Manzoor, T. Ali, M. Asim, G. Muhammad, A. Ahmad, M.I. Jamaludin, et al.

  • Journal: American Journal of Cancer Research, 14(8), 4028

  • Year: 2024

  • Citations: 1

11. Understanding the Role of Pharmacology and Toxicology in the Research, Development, and Innovation Process by Analyzing the Drug Development Process

  • Authors: L. Waheed, I. Ur Rehman, S. Devaraj, F.H.G.Q. Al-Amier, P. Jativa, G. Naz, et al.

  • Journal: Journal of Pharmaceutical Negative Results, Vol. 14

  • Year: 2023

  • Citations: 1

Hafiz Hussain | Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Assist. Prof. Dr. Hafiz Hussain | Pharmaceutical Science | Best Researcher Award

Assistant Professor at Cholistan University of Veterinary and Animal Sciences Bahawalpur, Pakistan

Dr. Hafiz Iftikhar Hussain is an esteemed Assistant Professor in the Department of Pathology at Cholistan University of Veterinary and Animal Sciences (CUVAS), Bahawalpur, Pakistan. With a strong background in veterinary pathology, he has made significant contributions to research and academia. His expertise lies in bacterial and viral disease pathology in poultry and livestock, with a focus on antibiotic resistance and molecular diagnostics. Dr. Hussain has extensive experience in research methodologies, including whole-genome sequencing, transcriptomic profiling, and biofilm detection. As a dedicated academician, he also serves as Coordinator for undergraduate programs and Additional Director of Student Affairs at CUVAS. He is an active member of several professional associations, including the Pakistan Veterinary Medical Council and the Pakistan Biological Safety Association. His commitment to scientific excellence is evident through his numerous publications, conference presentations, and roles as a reviewer for prestigious journals. Dr. Hussain’s passion for advancing veterinary sciences, particularly in pathology and disease control, underscores his professional journey. His remarkable achievements, including scholarships, best paper awards, and active participation in national and international conferences, reflect his dedication to research, education, and the betterment of animal health sciences in Pakistan and beyond.

Professional Profile

Education

Dr. Hafiz Iftikhar Hussain has an impressive academic background in veterinary sciences and pathology. He earned his Doctor of Philosophy (PhD) in Basic Veterinary Medicine, specializing in Pathobiology, from Huazhong Agricultural University, China, in 2017, with an outstanding score of 81.75%. Prior to his PhD, he completed a Master of Philosophy (M.Phil) in Pathology from the University of Agriculture, Faisalabad, in 2012, focusing on histopathology and toxicology with a commendable CGPA of 3.81/4.00. His foundational education includes a Doctor of Veterinary Medicine (DVM) degree from the University of Agriculture, Faisalabad, completed in 2010, with a CGPA of 3.26/4.00. Dr. Hussain began his academic journey with a Higher Secondary School Certification (F.Sc. Pre-Medical) from the Federal Board of Intermediate and Secondary Education, Islamabad, securing 74% marks in 2005. His early education was completed with a Secondary School Certification in Science from the Board of Intermediate and Secondary Education, Sargodha, where he achieved an excellent 85.77% in 2003. His strong educational foundation has equipped him with advanced knowledge in veterinary pathology, toxicology, and molecular diagnostics, laying the groundwork for his research and academic pursuits in veterinary sciences.

Professional Experience

Dr. Hafiz Iftikhar Hussain has amassed extensive professional experience in veterinary pathology and academia. His career began as a self-employed veterinary doctor at Al-Shifa Veterinary Clinic and Lab in Farooka, Sargodha, from August 2012 to August 2013. He then transitioned to academia as an Assistant Professor in the Department of Veterinary Pathology at PMAS-Arid Agriculture University, Rawalpindi, where he served from July to December 2018. Since December 2018, Dr. Hussain has been an Assistant Professor in the Department of Pathology at Cholistan University of Veterinary and Animal Sciences (CUVAS), Bahawalpur. Alongside his teaching responsibilities, he plays a crucial administrative role as the Coordinator for BS Doctor of Veterinary Medicine (DVM) and BS Medical Laboratory Technology programs. Additionally, he serves as the Additional Director of Student Affairs at CUVAS, demonstrating his leadership and commitment to academic excellence. Dr. Hussain is an active member of professional organizations such as the Pakistan Veterinary Medical Council and the Pakistan Biological Safety Association. His experience spans both clinical practice and academia, making him a distinguished figure in veterinary pathology and a mentor for aspiring veterinarians in Pakistan.

Research Interests

Dr. Hafiz Iftikhar Hussain’s research interests lie at the intersection of veterinary pathology, microbiology, and molecular diagnostics. His primary focus is on antibiotic resistance mechanisms, bacterial pathogenesis, and molecular characterization of multidrug-resistant pathogens, particularly Escherichia coli in poultry. He has conducted extensive research on extended-spectrum beta-lactamase (ESBL) detection and whole-genome sequencing to understand resistance genes in bacterial populations. His studies also explore the pathogenesis of viral and bacterial diseases in poultry and livestock, with an emphasis on biofilm formation and detection. Additionally, Dr. Hussain has a keen interest in transcriptomic profiling, protein extraction, and the development of animal models to study disease mechanisms. His research contributes to the global fight against antimicrobial resistance, aiming to develop strategies for better disease control and prevention in veterinary medicine. As an advocate for One Health, he also investigates zoonotic disease transmission and its implications for public health. His work has been widely recognized, earning him numerous publications in high-impact journals and invitations to present at international conferences. Through his research, Dr. Hussain strives to enhance disease diagnosis, treatment, and control strategies to improve animal and human health.

Research Skills

Dr. Hafiz Iftikhar Hussain possesses a comprehensive skill set in veterinary pathology and molecular diagnostics. His expertise includes antibiotic resistance determination, extended-spectrum beta-lactamase (ESBL) detection, and whole-genome re-sequencing. He is proficient in high-performance liquid chromatography (HPLC), polymerase chain reaction (PCR), and DNA, RNA, and protein extraction techniques. His research capabilities extend to RNA sequencing, biofilm formation studies, enzyme-linked immunosorbent assay (ELISA), and spectrophotometry. Dr. Hussain is also experienced in developing cell lines and utilizing animal modeling for disease studies. In addition to his laboratory skills, he is well-versed in various bioinformatics tools, enabling him to analyze complex genomic data efficiently. His proficiency in Microsoft Office, Adobe Photoshop for scientific presentations, and statistical analysis software further supports his research endeavors. Dr. Hussain’s technical expertise has been instrumental in advancing his research on antimicrobial resistance, bacterial pathogenesis, and disease diagnostics. His ability to integrate traditional pathology techniques with modern molecular approaches makes him a valuable contributor to veterinary sciences. With a strong commitment to continuous learning and innovation, he remains at the forefront of veterinary research, working to enhance disease control strategies in animal health.

Awards and Honors

Dr. Hafiz Iftikhar Hussain has received numerous accolades for his academic and research contributions. He was awarded a scholarship from the Chinese Scholarship Council for his PhD studies at Huazhong Agricultural University. Throughout his education, he was a consistent scholarship holder from grade six to his PhD. In recognition of his outstanding research, he won the ‘Best Student Paper Award’ at the First Annual Academic Symposium for International Students in 2018 at Huazhong Agricultural University. His academic achievements include earning the esteemed Sahadat-e-Hifz-ul-Quran certification from Wafaq-ul-Madaris, Islamabad. As a recognized expert, Dr. Hussain is a certified reviewer for the ‘Antimicrobial Resistance & Infection Control’ journal and serves as a reviewer for high-impact journals, including Frontiers in Veterinary Science and PLOS ONE. His dedication to veterinary sciences and research has positioned him as a leader in his field, making significant contributions to veterinary pathology and microbiology. These honors reflect his unwavering commitment to excellence, research innovation, and the advancement of animal health sciences at both national and international levels.

Conclusion

Dr. Hafiz Iftikhar Hussain stands as a distinguished figure in veterinary pathology, academia, and research. His extensive expertise in bacterial and viral disease pathology, antimicrobial resistance, and molecular diagnostics has significantly contributed to veterinary sciences. With a strong academic background, he has successfully combined clinical practice, teaching, and research to mentor future veterinarians. His role as an Assistant Professor, program coordinator, and student affairs director at CUVAS demonstrates his leadership and dedication to education. Through his research, he has made remarkable advancements in understanding antibiotic resistance and bacterial pathogenesis, earning prestigious awards and international recognition. His technical skills in genomics, pathology, and bioinformatics further enhance his contributions to disease control and prevention. As an active member of professional organizations and a reviewer for high-impact journals, Dr. Hussain continues to influence the field of veterinary medicine. His commitment to scientific excellence and student mentorship underscores his vision for a healthier future in veterinary and public health. His work remains instrumental in shaping the next generation of veterinary professionals and improving animal health through innovative research and education.

Publications Top Notes

  1. “Optimization and production of highly stable amylase isolated from Citrobacter portucalensis using low-cost agro-industrial wastes as substrates: Prospective therapeutics”

    • Authors: Ume E. Salma Liaqat, Shumaila Naz, Hafiz Iftikhar Hussain
    • Year: 2024
    • Journal: Kuwait Journal of Science

  2. “Phytochemical Screening, Anti-Inflammatory, and Antidiabetic Activities of Different Extracts from Caralluma edulis Plant”

    • Authors: Maria Khan, Zahid Manzoor, Muhammad Q. Rafiq, Katarzyna Kotwica-Mojzych, Mariusz Mojzych
    • Year: 2022
    • Journal: Molecules
    • Citations: 9

 

Radhika Khanna | Medicinal Chemistry | Best Researcher Award

Posted on by ScienceFather

Ms. Radhika Khanna | Medicinal Chemistry | Best Researcher Award

Researcher at Forest Research Institute, India

Radhika Khanna is a dedicated researcher pursuing her Ph.D. at the Forest Research Institute (FRI), Dehradun. With a strong foundation in chemistry and years of experience in advanced analytical techniques, she has carved a niche in the fields of chemical characterization, conservation, and natural product research. Radhika has actively contributed to both academia and applied research, with multiple publications, including in high-impact journals such as the Journal of Ethnopharmacology. She holds a patent for a formulation addressing diabetes management, reflecting her commitment to creating solutions with societal relevance. Her participation in numerous national and international conferences, including the Young Scientist Conference (IISF 2023), underscores her engagement with the global scientific community. Radhika’s technical acumen in spectroscopy, chromatography, and her ability to leverage computational tools enhance her innovative research efforts.

Professional Profile

Education

Radhika Khanna’s educational journey demonstrates consistency and academic excellence. She completed her secondary education at Shri Ram Ashram Public School, Amritsar, achieving a commendable CGPA of 8.4. She then pursued her higher secondary education at Bhavans SL Public School, Amritsar, scoring 84%. For her undergraduate studies, she earned a B.Sc. in Medical Science from S.R. Government College, Amritsar, with a percentage of 65.75%. She went on to complete her M.Sc. in Chemistry at Khalsa College, Amritsar, graduating with an impressive 75%. Currently, Radhika is pursuing her Ph.D. at the prestigious Forest Research Institute (FRI), Dehradun, where her research focuses on the chemical characterization of forest genetic resources and natural product development.

Professional Experience

Radhika Khanna has garnered diverse research experience through impactful projects and academic roles. She initiated her research career during her postgraduate studies with a project on the design and synthesis of Schiff base-based chemosensors under the guidance of Dr. Kuljit Kaur at Khalsa College, Amritsar. This project honed her skills in advanced chemical synthesis and analysis. Currently, as a Ph.D. scholar at the Forest Research Institute, Dehradun, she is involved in the chemical characterization of forest genetic resources, guided by Dr. V.K. Varshney. These experiences have equipped her with expertise in analytical techniques, conservation strategies, and natural product research. Her active participation in international conferences further reflects her professional commitment to knowledge sharing and collaboration.

Research Interest

Radhika’s research interests lie in the fields of analytical chemistry, natural product development, and conservation science. She is passionate about exploring the chemical properties of forest genetic resources to unlock their potential for pharmaceutical and environmental applications. Her work focuses on the design and synthesis of chemosensors, which have significant applications in chemical detection and environmental monitoring. Additionally, she is deeply invested in the characterization of natural antioxidants and anti-inflammatory compounds, as demonstrated by her publications and patent on diabetes management. Radhika’s interdisciplinary research bridges analytical chemistry, pharmacology, and conservation, with the overarching goal of advancing sustainable and innovative solutions to global challenges.

Research Skills

Radhika Khanna possesses a robust skill set encompassing advanced analytical and computational techniques. Her expertise includes UV and IR spectroscopy, GCMS, HPLC, LCMS, column chromatography, and flash chromatography, which are vital for chemical analysis and natural product research. She is also proficient in software tools such as Corel Draw, Adobe Photoshop, and MS Office, as well as programming languages like C++ and HTML. These technical skills, combined with her proficiency in research methodologies, allow her to approach problems innovatively and efficiently. Furthermore, her hands-on experience in chemical synthesis, characterization, and conservation science underscores her capability to conduct interdisciplinary research.

Awards and Honors

Radhika Khanna’s dedication to research has earned her recognition at numerous national and international platforms. She has presented her work at prestigious events such as the Young Scientist Conference (IISF 2023) and the International Conference on Biodiversity & Bioprospecting in Kathmandu, Nepal. Her contributions to science have also been recognized at national conferences, including the Uttarakhand State Science and Technology Congress. Additionally, she has earned certifications in IT foundation programs and personality development, enhancing her holistic skillset. Her innovative research efforts are further highlighted by her patent for a formulation addressing diabetes management, cementing her reputation as a researcher committed to impactful and solution-driven science.

Conclusion

Radhika Khanna is a promising candidate for the Best Researcher Award based on her technical skills, active participation in the scientific community, and impactful research outputs such as a patent and publications. However, enhancing the specialization depth of her research, increasing her publication count, and gaining more diversified professional experience would solidify her position as a top contender. Given her strengths, Radhika is a worthy nominee, particularly in categories emphasizing innovation and technical expertise.

Publication Top Notes

  1. In vitro and in vivo anti-inflammatory activity of Cupressus torulosa D. DON needles extract and its chemical characterization
    • Authors: R Khanna, K Bhadoriya, YC Tripathi, VK Varshney
    • Year: 2023
    • Journal: Journal of Ethnopharmacology
    • Citations: 4
  2. Cupressus torulosa, a Source of Antioxidant Polyphenols: An Analytical and Pharmacological Study
    • Authors: R Khanna, HR Chitme, K Bhadoriya, VK Varshney
    • Year: 2025
    • Journal: Rapid Communications in Mass Spectrometry
  3. Toxicity studies, Hypoglycaemic activity of Cupressus torulosa needles and recognition of active molecules
    • Authors: R Khanna
    • Year: 2023
    • Journal: MDPI

 

 

 

Mehlika Dilek Altıntop | Medicinal Chemistry | Women Researcher Award

Posted on by ScienceFather

Dr. Mehlika Dilek Altıntop | Medicinal Chemistry| Women Researcher Award

Professor Doctorate of Anadolu University, Faculty of Pharmacy, Eskişehir, Turkey.

Mehlika Dilek Altıntop is a researcher specializing in the synthesis of bioactive compounds with therapeutic potential for cancer and metabolic disorders. Her work focuses on designing and evaluating enzyme inhibitors, particularly aldose reductase inhibitors for diabetes treatment. In pharmaceutical chemistry, she investigates new chemical entities with antimicrobial and anticancer activities. Altıntop also explores molecular hybridization to enhance biological activity and is involved in drug development, including the creation of innovative compounds like triazolothiadiazine derivatives. Her research contributes significantly to advancing treatment options and improving therapeutic outcomes.

Profile

Education:

Mehlika Dilek Altıntop’s educational journey began at İkieylül Elementary School, where she completed her primary education from 1991 to 1996. She then attended Eskişehir Anatolian High School for her secondary and high school education from 1996 to 2003. Pursuing higher education, she enrolled at Anadolu University, Faculty of Pharmacy, graduating with her undergraduate degree in 2007. She continued her academic career at Anadolu University, where she completed a Master’s Degree with Thesis in Pharmaceutical Chemistry at the Graduate School of Health Sciences between 2007 and 2009. Subsequently, she earned her Doctoral Degree in Pharmaceutical Chemistry from the same institution, graduating in 2012. Additionally, she possesses an excellent command of English, which complements her academic and professional expertise.

Academic Titles:

Prof. Dr. Mehlika Dilek Altıntop has had a distinguished career at Anadolu University, Faculty of Pharmacy. She began as a Research Assistant from 2010 to 2012, where she gained foundational experience in pharmaceutical research. She then advanced to the role of Research Assistant Doctor from 2012 to 2014, further deepening her expertise. Her career continued to progress as she took on the position of Assistant Professor Doctor from 2014 to 2015, during which she began to establish her reputation in the field. In 2015, she was promoted to Associate Professor Doctor, a role she held until 2020. Since 2020, Prof. Dr. Altıntop has served as a Professor Doctor at Anadolu University, where she continues to contribute significantly to the field of pharmacy through both her research and teaching activities. Her career reflects a consistent trajectory of academic growth and leadership.

Awards:

Prof. Dr. Mehlika Dilek Altıntop has received numerous accolades throughout her distinguished career. In 2007, she was honored with the Anadolu University Faculty of Pharmacy Championship Award and the Graduate Scholarship from The Scientific and Technological Research Council of Turkey. Her exceptional contributions were further recognized with the Anadolu University Science and Technology Encouragement Award and several Article Performance Awards from 2014 to 2018. She achieved the Gold and Platinum Article Performance Awards in 2015 and was named Outstanding Reviewer by the European Journal of Medicinal Chemistry in 2016. In 2019, she received the Turkish Pharmacists’ Association Academy of Pharmacy Encouragement Award. Prof. Altıntop was awarded the Anadolu University Academic Outstanding Success Award in 2020 and 2021 and recognized as the Outstanding Woman Researcher in Pharmaceutical Chemistry at VIWA 2021. Her invention, “Targeted Novel Triazolothiadiazine Derivatives for The Treatment of Lung Cancer,” earned a Silver Medal at ISIF’21. Her top-cited articles in Archiv der Pharmazie and Open Chemistry further highlight her impactful research.

 

Dr. Mehlika Dilek Altıntop’s research focuses on medicinal chemistry, with a particular emphasis on:

Mehlika Dilek Altıntop’s research is centered on the synthesis and development of bioactive compounds with significant therapeutic potential, particularly for cancer and metabolic disorders. Her work involves designing and evaluating enzyme inhibitors, such as aldose reductase inhibitors, to address conditions like diabetes. In pharmaceutical chemistry, she investigates new chemical entities and their pharmacological effects, including antimicrobial and anticancer properties. A key aspect of her research is molecular hybridization, where she combines different molecular scaffolds to enhance biological activity. Her focus on drug development includes the creation and testing of innovative drugs, exemplified by her work on triazolothiadiazine derivatives and other novel compounds. Altıntop’s contributions aim to advance therapeutic options and improve treatment outcomes across a range of medical conditions.

PUBLICATION TOP NOTES:

  1. “Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy”
    Altıntop, M.D., Ertorun, İ., Akalın Çiftçi, G., Özdemir, A.
    European Journal of Medicinal Chemistry, 2024
  2. “Design, Synthesis, and In Vivo Evaluation of a New Series of Indole-Chalcone Hybrids as Analgesic and Anti-Inflammatory Agents”
    Baramaki, I., Altıntop, M.D., Arslan, R., Hasan, A., Bektaş Türkmen, N.
    ACS Omega, 2024
  3. “Design, Synthesis, and Evaluation of a New Series of 2-Pyrazolines as Potential Antileukemic Agents”
    Altıntop, M.D., Cantürk, Z., Özdemir, A.
    ACS Omega, 2023
  4. “Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy”
    Erdönmez, B., Altıntop, M.D., Akalın Çiftçi, G., Özdemir, A., Ece, A.
    ACS Omega, 2023
  5. “A new series of hydrazones as small-molecule aldose reductase inhibitors”
    Altıntop, M.D., Demir, Y., Türkeş, C., Beydemir, Ş., Özdemir, A.
    Archiv der Pharmazie, 2023
  6. “A new series of thiazole-hydrazone hybrids for Akt-targeted therapy of non-small cell lung cancer”
    Orujova, T., Ece, A., Akalın Çiftçi, G., Özdemir, A., Altıntop, M.D.
    Drug Development Research, 2023
  7. “Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action”
    Altıntop, M.D., Akalın Çiftçi, G., Yılmaz Savaş, N., Alataş, Ö., Özdemir, A.
    International Journal of Molecular Sciences, 2023
  8. “Microwave-assisted synthesis of a series of 4,5-dihydro-1H-pyrazoles endowed with selective COX-1 inhibitory potency”
    Altıntop, M.D., Temel, H.E., Özdemir, A.
    Journal of the Serbian Chemical Society, 2023
  9. “Design, synthesis and biological evaluation of a new series of arylidene indanones as small molecules for targeted therapy of non-small cell lung carcinoma and prostate cancer”
    Altıntop, M.D., Özdemir, A., Temel, H.E., Kaplancıklı, Z.A., Akalın Çiftçi, G.
    European Journal of Medicinal Chemistry, 2022

 

 

 

Ahmet Ozdemir | Medicinal Chemistry | Best Researcher Award

Posted on by ScienceFather

Dr Ahmet Ozdemir | Medicinal Chemistry | Best Researcher Award

Professor Doctorate, Anadolu University ,Turkey.

Ahmet ÖZDEMİR, born on July 24, 1972, in Muğla, Turkey, is a Professor of Pharmaceutical Chemistry at Anadolu University, where he has been a faculty member since 1997. He earned his undergraduate degree in Pharmacy from Anadolu University (1990-1994), followed by an M.Sc. in Pharmaceutical Chemistry (1995-1996) and a Ph.D. in the same field (1996-2004), with research focusing on the synthesis and biological activities of novel compounds. Dr. ÖZDEMİR has held various academic positions at Anadolu University, advancing from Research Assistant to Professor. He has also served in administrative roles, including Associate Director of Anadolu University Yunus Emre Vocational School and Vice Academic Director of the Open Education Faculty’s Department of Health Administration. His research is well-regarded, earning him multiple awards, including the Anadolu University Article Performance Award and the ISIF’21 Silver Medal for his work on targeted novel triazolothiadiazine derivatives for lung cancer treatment.

Profile:

Education

Prof. Dr. Ahmet Özdemir’s educational journey began at Salihli Cumhuriyet Elementary School, where he completed his primary education from 1978 to 1983. He continued his secondary education at Salihli 50. Yıl Secondary School from 1983 to 1986, and then attended Salihli High School from 1986 to 1989, where he completed his high school education. Prof. Dr. Özdemir pursued his undergraduate studies at Anadolu University Faculty of Pharmacy, graduating in 1994. He furthered his education with a Master’s Degree in Pharmaceutical Chemistry at Anadolu University’s Graduate School of Health Sciences from 1995 to 1996, where he completed his thesis. He continued at Anadolu University for his Doctoral Degree in Pharmaceutical Chemistry, which he achieved in 2004. Additionally, he possesses intermediate proficiency in English, which complements his academic background and research expertise.

Academic Titles

Prof. Dr. Ahmet Özdemir’s academic career at Anadolu University’s Faculty of Pharmacy spans several roles and achievements. He began his journey as a Research Assistant in 1997, a position he held until 2004. Following this, he advanced to the role of Research Assistant Doctor, continuing his work at the same institution from 2004 to 2005. Dr. Özdemir was then appointed as a Lecturer from 2005 to 2007, showcasing his growing expertise in the field. His contributions were recognized with a promotion to Assistant Professor Doctor, a role he embraced from 2007 to 2010. His exceptional work led to his promotion to Associate Professor Doctor, a position he held from 2010 to 2015. Since 2015, Prof. Dr. Özdemir has served as Professor Doctor, continuing to make significant contributions to the Faculty of Pharmacy and the broader academic community.

Awards

Prof. Dr. Ahmet Özdemir has received several prestigious awards for his academic and research contributions. In 2014, he was honored with the Anadolu University Article Performance Award. His outstanding achievements continued with the Anadolu University Gold Article Performance Award and the Anadolu University Platinum Article Performance Award in 2015. He maintained a high standard of excellence, receiving the Anadolu University Article Performance Award annually from 2016 to 2018. In 2019, Dr. Özdemir was recognized with the Anadolu University Academic Success Award. His consistent performance earned him the Anadolu University Article Performance Award again in 2020. Notably, in 2021, he was awarded the ISIF’21 Silver Medal for the invention titled “Targeted Novel Triazolothiadiazine Derivatives for the Treatment of Lung Cancer” at the 6th Istanbul International Inventions Fair (ISIF’21). This award was shared with Assoc. Prof. Dr. Belgin Sever, Prof. Dr. Mehlika Dilek Altintop, and Prof. Dr. Gülşen Akalın Çiftçi.

Research Focus

Prof. Dr. Ahmet Özdemir’s research is dedicated to the field of medicinal chemistry, with a keen focus on several key areas. He specializes in the synthesis of bioactive compounds, aiming to develop novel chemical entities with potential therapeutic uses, particularly targeting antifungal and antibacterial applications. His work in pharmaceutical chemistry involves investigating the physicochemical properties of these compounds, which has significant implications for drug design and efficacy. Dr. Özdemir also explores antimicrobial agents, focusing on the synthesis and evaluation of compounds designed to combat bacterial and fungal pathogens. In the realm of drug design and development, he examines structure-activity relationships to create effective and selective pharmaceutical agents. Additionally, his contributions extend to invention and innovation, where he develops novel chemical derivatives, such as triazolothiadiazine derivatives, for potential applications in treating diseases like lung cancer.

Publications

  1. “Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy”
    • Authors: Altıntop, M.D., Ertorun, İ., Akalın Çiftçi, G., Özdemir, A.
    • Year: 2024
  2. “Design, Synthesis, and In Vivo Evaluation of a New Series of Indole-Chalcone Hybrids as Analgesic and Anti-Inflammatory Agents”
    • Authors: Baramaki, I., Altıntop, M.D., Arslan, R., Hasan, A., Bektaş Türkmen, N.
    • Year: 2024
  3. “Design, Synthesis, and Evaluation of a New Series of 2-Pyrazolines as Potential Antileukemic Agents”
    • Authors: Altıntop, M.D., Cantürk, Z., Özdemir, A.
    • Year: 2023
  4. “Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy”
    • Authors: Erdönmez, B., Altıntop, M.D., Akalın Çiftçi, G., Özdemir, A., Ece, A.
    • Year: 2023
  5. “A new series of hydrazones as small-molecule aldose reductase inhibitors”
    • Authors: Altıntop, M.D., Demir, Y., Türkeş, C., Beydemir, Ş., Özdemir, A.
    • Year: 2023
  6. “A new series of thiazole-hydrazone hybrids for Akt-targeted therapy of non-small cell lung cancer”
    • Authors: Orujova, T., Ece, A., Akalın Çiftçi, G., Özdemir, A., Altıntop, M.D.
    • Year: 2023
  7. “Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action”
    • Authors: Altıntop, M.D., Akalın Çiftçi, G., Yılmaz Savaş, N., Alataş, Ö., Özdemir, A.
    • Year: 2023
  8. “Microwave-assisted synthesis of a series of 4,5-dihydro-1H-pyrazoles endowed with selective COX-1 inhibitory potency”
    • Authors: Altıntop, M.D., Temel, H.E., Özdemir, A.
    • Year: 2023
  9. “Design, synthesis and biological evaluation of a new series of arylidene indanones as small molecules for targeted therapy of non-small cell lung carcinoma and prostate cancer”
    • Authors: Altıntop, M.D., Özdemir, A., Temel, H.E., Kaplancıklı, Z.A., Akalın Çiftçi, G.
    • Year: 2022
  10. “A new series of thiosemicarbazone-based anti-inflammatory agents exerting their action through cyclooxygenase inhibition”
    • Authors: Altıntop, M.D., Sever, B., Akalın Çiftçi, G., Alataş, Ö., Özdemir, A.
    • Year: 2022